
The roots of our organization can be traced back to research work begun in 1991, which focused on the development of computer-aided detection systems for the early detection of lung cancer. Today, Riverain offers OnGuardTM, the only chest X-ray CAD system for early lung cancer detection that is FDA-PMA approved.